Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Gynecol Oncol. 2016 Jun 4;142(2):217–224. doi: 10.1016/j.ygyno.2016.05.035

Table 3.

Postoperative outcomes associated with diverting ileostomy

Variable No DI
(n=287)
DI
(n=44)
p

n % n %

Median postoperative length of stay, days (range) 9
(3–69)
10
(5–30)
.25

Major (Grade 3/4/5) postoperative complications
  0 220 77 31 70 .41
  1–2 63 22 13 30
  3 or more 4 1 0 0

Gastrointestinal complications
  No 212 74 32 72.7 .87
  Yes 75 26 12 27.3

Anastomotic leak
  No 268 93 42 95.5 .60
  Yes 19 7 2 4.5

Intra-abdominal abscess
  No 264 92 35 79.5 .02a
  Yes 23 8 9 20.5

Wound infection
  No 250 87 41 93.2 .25
  Yes 37 13 3 6.8

Readmission within 30 days of surgery
  No 239 83 34 77.3 .33
  Yes 48 17 10 22.7

Readmission within 60 days of surgery
  No 225 78 30 68.2 .13
  Yes 62 22 14 31.8

Median time from surgery to start of
chemotherapy, days (range)
40
(9–115)
41
(11–75)
.20

Number of postoperative chemotherapy cycles
  0–4 10 3.6 2 4.8 .66
  5 or more 269 96.4 40 95.2

DI, diverting ileostomy

a

Non-significant on multivariable analysis